Executive Director, US Brand Lead – Oncology Biosimilars

Amgen Inc. (IR) seeks a senior executive to lead the US commercial market readiness for two oncology biosimilars, ABP 206 and ABP 234. The role requires extensive cross-functional collaboration and strategic market positioning to drive long-term success.
The ideal candidate has advanced oncology commercialization experience and demonstrated leadership across large, matrixed organizations, with a focus on market access, contracting, and competitive differentiation.

#J-18808-Ljbffr